slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 27,361-27,390
Pages 1,371
Rows per page 30
Component
27,361-27,390 of 41,127
02
Auto Trader Group | Investor Day Presentation Deck | 100 slidesAuto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Beat · Attention1 hit
01
Includes company logo and ticker symbol.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
02
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
17
Clinical trial data showing statistically significant reductions in ALT for AXA1125 groups compared to placebo.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
Shows statistically significant effects at week 12 for AXA1125 treatment arms.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
21
DMC = Data Monitoring Committee; TEAE = Treatment Emergent Adverse Event; SAE = Serious Adverse Event.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
25
The slide uses a central biological pathway map (liver/metabolic focus) flanked by comparison tables showing single-target competitors vs AXA1125's multi-target effects.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
43
The slide compares three groups (Placebo, AXA1125 22.6 BID, AXA1125 33.9 BID) across two time points (Week 12 and Week 24).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
52
The slide highlights the efficacy of MGL-3196 in NASH treatment using MRI-PDFF as a biomarker.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
60
The slide uses checkmarks to indicate completed milestones.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
62
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
02
AYRO | Investor Presentation Deck | 29 slidesAYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Humble Origins1 hit
06
The slide uses a central value proposition statement supported by product imagery.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
03
The slide uses a two-column layout (Customers vs Partners) overlaid on a world map, with key metrics represented as circular callouts.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Humble OriginsLoop · Logic Chain1 hit
04
Includes a disclaimer about accounting standards (Dutch GAAP vs IFRS) and pro forma assumptions.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Humble OriginsLoop · Logic Chain1 hit
07
The slide uses a central donut chart for gender/total plays, flanked by two bar charts for age and geography, with game icons arranged in a circle.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
10
The slide uses a funnel-like visual to show how Azerion consolidates services compared to competitors who are more specialized.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
16
The slide uses a timeline-like structure to showcase inorganic growth.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
25
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
26
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
02
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations 1 hit
47
The slide uses a flow-chart to illustrate an adaptive clinical trial design.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
02
BMO Capital Markets | Investment Banking Pitch Book | 22 slidesBMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & Context1 hit
03
The slide compares the Turquoise Hill benchmark against the Rio Tinto proposal across various financial and structural dimensions.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
04
The chart illustrates the market reaction to the Rio Tinto offer, showing the initial premium and the current premium relative to the peer group index.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
09
The chart overlays transaction events (producers vs developers) onto a historical copper price time series.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
11
The slide uses a waterfall-style chart to compare valuation ranges across different methodologies, with a clear distinction between 'Core Methodologies' and 'Informational Purposes'.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank 1 hit
17
The chart includes a median benchmark and implied TRQ share prices for each entity.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
18
The chart uses a horizontal bar format to show percentage performance relative to a baseline, with a median highlighted.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
19
The chart highlights Turquoise Hill (Model) in light blue and includes a vertical line indicating the median P/NAV of 0.27x.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit